The Top Line cover image

Teva’s CEO shares ‘Pivot to Growth’ progress

The Top Line

00:00

Navigating Generics and Biosimilars

This chapter discusses a company's dedication to its generics and biosimilars, highlighting the challenges of adoption in the US market. It also covers strategic shifts aimed at reducing reliance on US sales and focusing on international expansion and innovative products for long-term growth.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app